secwatch.observer — SEC 8-K summary
======================================

Issuer:     GUIDED THERAPEUTICS INC (GTHP)
CIK:        0000924515
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001477932-26-001252
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guided Therapeutics completes warrant exchange; issues 4.825M shares for $980K cash
--------------------------------------------------------------------------------

- Holders of 4.825M eligible warrants (22.7% of total) tendered; exchanged for restricted common stock at reduced exercise prices.
- Exercise price for $0.65 warrants reduced to $0.25; for $0.50 warrants reduced to $0.20, generating $980K total cash proceeds.
- After exchange, company has 91.5M shares outstanding; 16.4M eligible warrants remain, most expiring Sep–Oct 2026.
- Remaining unexercised warrants held by participating holders have expiration extended by one year.
- Shares issued under Section 3(a)(9) exemption; no commissions paid for solicitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/924515/000147793226001252/0001477932-26-001252-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/924515/000147793226001252/gthp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-001252

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer